Nang Kuang Pharm Co Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NANG KUANG PHARM CO, and what generic and branded alternatives to NANG KUANG PHARM CO drugs are available?
NANG KUANG PHARM CO has five approved drugs.
Drugs and US Patents for Nang Kuang Pharm Co
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nang Kuang Pharm Co | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 207352-001 | May 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nang Kuang Pharm Co | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 207352-002 | May 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nang Kuang Pharm Co | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;IV (INFUSION) | 206554-001 | Jun 7, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Nang Kuang Pharm Co | IBANDRONATE SODIUM | ibandronate sodium | INJECTABLE;INTRAVENOUS | 204329-001 | Jun 16, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Nang Kuang Pharm Co | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;IV (INFUSION) | 206554-002 | Jun 7, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.